Has anyone died from taking GLP-1 weight-loss drugs? – Baltimore Sun
Has anyone died from taking GLP-1 weight-loss drugs? Baltimore SunPAHO calls for strengthened pharmacovigilance following reports of misuse of…
Table 2.0: Restaurants absorb ‘Ozempic effect’ for weight-loss drug consumers
New Delhi:Dozens of Indian restaurants and cafe chains are fast-tracking Size O menus — the O standing for…
Mounjaro ingredient shows promise in lowering alcohol consumption
For the first time, researchers show that tirzepatide – the active ingredient in the diabetes and weight-loss drug…
Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasible
HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
New weight-loss pill: 6 things you should know – Caledonian Record
New weight-loss pill: 6 things you should know Caledonian RecordNovo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete…
New drug CagriSema leads to 14% weight loss in trial
Share on PinterestNew combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to…
Health Canada warns of fake semaglutide drugs, cites ‘product safety’ risks – National
Health Canada is warning Canadians of the dangers of buying “fake or unauthorized products” meant to replicate popular…
How bariatric surgery outperforms GLP-1 in body fat loss
A large real-world study reveals how surgery and GLP-1 therapies reshape fat and lean tissue differently over time,…
What is 'natural Ozempic' – and how good is the science? – The i Paper
What is ‘natural Ozempic’ – and how good is the science? The i PaperThe viral ‘oatzempic’ drink trend: Does…
New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
Eli Lilly Drug Retatrutide Clinical Trial Results
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
Glucose-lowering drugs may reduce risk of developing epilepsy
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to…